alprazolam has been researched along with carbamazepine in 30 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (23.33) | 18.7374 |
| 1990's | 9 (30.00) | 18.2507 |
| 2000's | 7 (23.33) | 29.6817 |
| 2010's | 7 (23.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Gao, F; Lombardo, F; Shalaeva, MY; Tupper, KA | 1 |
| Li, Y; Li, YH; Wang, YH; Yang, L; Yang, SL | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
| Artursson, P; Mateus, A; Matsson, P | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Browne, TR; Galpern, WR; Greenblatt, DJ; Miller, LG; Shader, RI; Szabo, GK | 1 |
| Altamura, AC; Mauri, MC; Percudani, M; Regazzetti, MG | 1 |
| Hales, RE; Sandberg, DP; Silver, JM | 1 |
| Klein, E; Post, RM; Uhde, TW | 1 |
| Gershon, S; Ortiz, A | 1 |
| Arana, GW; Epstein, S; Greenblatt, DJ; Molloy, M | 1 |
| Cowdry, RW; Gardner, DL | 2 |
| Clothier, J; Edlund, MJ; Swann, AC | 1 |
| Lawlor, BA | 1 |
| Campbell, M; Cueva, JE | 1 |
| Colin, V; Klein, E; Lenox, RH; Stolk, J | 1 |
| Born, JD; Brichant, JF; Hans, P; Lamy, M; Pieron, F; Pieyns, P | 1 |
| Alderman, J; Greenblatt, DJ; Horst, WD; Preskorn, SH | 1 |
| Furukori, H; Kaneko, S; Kondo, T; Nagasaki, T; Ohkubo, T; Otani, K; Shimoyama, R; Sugawara, K; Yasui, N | 1 |
| Joye, F; Marion, F; Michoux, I; Orrillard, M; Parisot, R | 1 |
| Chan, JC; Saranasuriya, C; Waxman, BP | 1 |
| Dalal, MA; Himmerich, H; Müller, MB; Nickel, T | 1 |
| Malik, AK; Rani, S | 1 |
| Manicke, NE; Zhang, C | 1 |
| Boinpally, R; Chen, L; Gad, N; Ghahramani, P; Greenberg, WM; Periclou, A; Wangsa, J | 1 |
6 review(s) available for alprazolam and carbamazepine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Alternative prophylactic treatments to lithium in bipolar disorders.
Topics: Alprazolam; Bipolar Disorder; Calcium Channel Blockers; Carbamazepine; Clonazepam; Humans; Lithium; Valproic Acid | 1990 |
New approaches in the pharmacotherapy of posttraumatic stress disorder.
Topics: Alprazolam; Antidepressive Agents; Carbamazepine; Humans; Lithium; Lithium Carbonate; Monoamine Oxidase Inhibitors; Stress Disorders, Post-Traumatic | 1990 |
The future of neuroleptic psychopharmacology.
Topics: Acute Disease; Aggression; Alprazolam; Antipsychotic Agents; Benzodiazepines; Carbamazepine; Clinical Trials as Topic; Combined Modality Therapy; Dose-Response Relationship, Drug; Drug Administration Schedule; Electroconvulsive Therapy; Humans; Kinetics; Lithium; Psychotic Disorders; Receptors, Dopamine; Schizophrenia; Violence | 1986 |
Suicidal and parasuicidal behavior in borderline personality disorder.
Topics: Adolescent; Adult; Alprazolam; Benzodiazepines; Borderline Personality Disorder; Carbamazepine; Dissociative Identity Disorder; Female; Humans; Personality Disorders; Psychotherapy; Psychotherapy, Group; Self Mutilation; Suicide; Suicide Prevention; Suicide, Attempted; Tranylcypromine; Trifluoperazine | 1985 |
Psychopharmacology in child and adolescent psychiatry: a review of the past seven years. Part II.
Topics: Adolescent; Alprazolam; Anticonvulsants; Antipsychotic Agents; Anxiety, Separation; Bipolar Disorder; Carbamazepine; Child; Child Behavior Disorders; Child, Preschool; Clonidine; Clozapine; Depressive Disorder; Dose-Response Relationship, Drug; Feeding and Eating Disorders; Fluoxetine; Humans; Imipramine; Lithium; Mutism; Obsessive-Compulsive Disorder; Phenobarbital; Phenytoin; Phobic Disorders; Schizophrenia; Sleep Wake Disorders; Tranquilizing Agents | 1995 |
5 trial(s) available for alprazolam and carbamazepine
| Article | Year |
|---|---|
The future of neuroleptic psychopharmacology.
Topics: Acute Disease; Aggression; Alprazolam; Antipsychotic Agents; Benzodiazepines; Carbamazepine; Clinical Trials as Topic; Combined Modality Therapy; Dose-Response Relationship, Drug; Drug Administration Schedule; Electroconvulsive Therapy; Humans; Kinetics; Lithium; Psychotic Disorders; Receptors, Dopamine; Schizophrenia; Violence | 1986 |
Pharmacotherapy of borderline personality disorder. Alprazolam, carbamazepine, trifluoperazine, and tranylcypromine.
Topics: Adult; Alprazolam; Ambulatory Care; Borderline Personality Disorder; Carbamazepine; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Female; Humans; Personality Disorders; Tranylcypromine; Trifluoperazine | 1988 |
Alprazolam withdrawal in patients with panic disorder and generalized anxiety disorder: vulnerability and effect of carbamazepine.
Topics: Adult; Alprazolam; Anxiety Disorders; Carbamazepine; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Male; Panic Disorder; Patient Dropouts; Placebos; Recurrence; Substance Withdrawal Syndrome; Survival Analysis; Treatment Outcome | 1994 |
Effect of carbamazepine on the single oral dose pharmacokinetics of alprazolam.
Topics: Adult; Alprazolam; Anti-Anxiety Agents; Anticonvulsants; Carbamazepine; Double-Blind Method; Half-Life; Humans; Male; Motor Activity; Psychomotor Performance | 1998 |
Evaluation of Cytochrome P450 (CYP) 3A4-Based Interactions of Levomilnacipran with Ketoconazole, Carbamazepine or Alprazolam in Healthy Subjects.
Topics: Adolescent; Adult; Alprazolam; Area Under Curve; Carbamazepine; Cyclopropanes; Cytochrome P-450 CYP3A Inducers; Cytochrome P-450 CYP3A Inhibitors; Delayed-Action Preparations; Drug Interactions; Female; Healthy Volunteers; Humans; Ketoconazole; Male; Middle Aged; Milnacipran; Young Adult | 2015 |
20 other study(ies) available for alprazolam and carbamazepine
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
ElogD(oct): a tool for lipophilicity determination in drug discovery. 2. Basic and neutral compounds.
Topics: 1-Octanol; Chromatography, High Pressure Liquid; Pharmaceutical Preparations; Solubility; Water | 2001 |
Modeling K(m) values using electrotopological state: substrates for cytochrome P450 3A4-mediated metabolism.
Topics: Computational Biology; Cyclohexanols; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Molecular Structure; Principal Component Analysis; Pyrrolizidine Alkaloids; Quantitative Structure-Activity Relationship; Reproducibility of Results; Substrate Specificity; Venlafaxine Hydrochloride | 2005 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |
A high-throughput cell-based method to predict the unbound drug fraction in the brain.
Topics: Animals; Brain; Dialysis; HEK293 Cells; High-Throughput Screening Assays; Humans; Pharmaceutical Preparations; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2014 |
Chronic benzodiazepine administration. IX. Attenuation of alprazolam discontinuation effects by carbamazepine.
Topics: Alprazolam; Animals; Anxiety; Carbamazepine; Cerebral Cortex; Disease Models, Animal; Drug Administration Schedule; Drug Evaluation, Preclinical; Hippocampus; Hypothalamus; Male; Mice; Motor Activity; Receptors, GABA-A; Seizures; Substance Withdrawal Syndrome; Time Factors | 1991 |
Preliminary evidence for the utility of carbamazepine in alprazolam withdrawal.
Topics: Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Carbamazepine; Female; Humans; Male; Panic; Substance Withdrawal Syndrome | 1986 |
Carbamazepine-induced reduction of plasma alprazolam concentrations: a clinical case report.
Topics: Adult; Alprazolam; Bipolar Disorder; Carbamazepine; Drug Interactions; Drug Therapy, Combination; Humans; Male | 1988 |
Patients with panic attacks and abnormal EEG results.
Topics: Adult; Alprazolam; Anxiety Disorders; Brain; Carbamazepine; Electroencephalography; Fear; Female; Humans; Male; Middle Aged; Panic; Temporal Lobe | 1987 |
Carbamazepine, alprazolam withdrawal, and panic disorder.
Topics: Alprazolam; Anxiety Disorders; Carbamazepine; Fear; Humans; Panic; Substance Withdrawal Syndrome | 1987 |
Elevated plasma alpha 1-acid glycoprotein levels: lack of connection to resistance to vecuronium blockade induced by anticonvulsant therapy.
Topics: Adult; Alprazolam; Anticonvulsants; Atropine; Biomarkers; Carbamazepine; Drug Interactions; Drug Resistance; Humans; Hydroxyzine; Hypnotics and Sedatives; Middle Aged; Neuromuscular Nondepolarizing Agents; Neurosurgery; Orosomucoid; Phenobarbital; Phenytoin; Vecuronium Bromide | 1997 |
Sertraline does not inhibit cytochrome P450 3A-mediated drug metabolism in vivo.
Topics: 1-Naphthylamine; Adolescent; Adult; Alprazolam; Aryl Hydrocarbon Hydroxylases; Biotransformation; Carbamazepine; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Humans; Male; Middle Aged; Oxidoreductases, N-Demethylating; Selective Serotonin Reuptake Inhibitors; Sertraline; Substrate Specificity; Terfenadine | 1997 |
[Severe intoxication probably from olanzapine (Zyprexa). Beneficial effect of glucagon].
Topics: Adult; Alprazolam; Antipsychotic Agents; Benzodiazepines; Bradycardia; Carbamazepine; Disseminated Intravascular Coagulation; Drug Therapy, Combination; Gastrointestinal Agents; Glucagon; Humans; Hypothermia; Infusions, Intravenous; Male; Methotrimeprazine; Olanzapine; Pirenzepine; Schizophrenia; Shock | 1999 |
Bezoar causing small bowel obstruction after repeated activated charcoal administration.
Topics: Adult; Alprazolam; Antimanic Agents; Bezoars; Carbamazepine; Charcoal; Female; Humans; Hypnotics and Sedatives; Ileal Diseases; Intestinal Obstruction; Sorption Detoxification; Suicide, Attempted | 2005 |
[Gabapentin treatment in a female patient with panic disorder and adverse effects under carbamazepine during benzodiazepine withdrawal].
Topics: Aged; Alprazolam; Amines; Antimanic Agents; Benzodiazepines; Carbamazepine; Chemical and Drug Induced Liver Injury; Cyclohexanecarboxylic Acids; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Gabapentin; gamma-Aminobutyric Acid; Humans; Liver Function Tests; Panic Disorder; Substance Withdrawal Syndrome | 2007 |
A novel microextraction by packed sorbent-gas chromatography procedure for the simultaneous analysis of antiepileptic drugs in human plasma and urine.
Topics: Alprazolam; Anticonvulsants; Carbamazepine; Epilepsy; Gas Chromatography-Mass Spectrometry; Humans; Oxcarbazepine; Phenytoin; Solid Phase Microextraction | 2012 |
Development of a Paper Spray Mass Spectrometry Cartridge with Integrated Solid Phase Extraction for Bioanalysis.
Topics: Alprazolam; Animals; Atenolol; Carbamazepine; Cattle; Diazepam; Mass Spectrometry; Paper; Solid Phase Extraction; Sulfamethazine | 2015 |